Inhibition of the myocardial mitochondria-STING-NFκB-ODC1 axis using genetic or pharmacological approaches significantly alleviated CKD-associated cardiac hypertrophy [35]. The gene discussed is ODC1; the disease is cardiac hypertrophy.